Understanding udder health
Last month we talked about why dry cow management is critical, though often overlooked. This month I wanted to dive further into the dry period’s importance to udder health.
A nationwide study to evaluate the effectiveness of a vaccine in controlling mastitis in dairy cattle is well underway and preliminary results are positive.
Southland veterinarian Dr Mark Bryan spoke about the preliminary data from the study, at the Pan Pacific Veterinary conference in Brisbane.
Mastitis, a bacterial infection of the udder, compromises the production and quality of milk and can impact growth rates and survival, leading to a loss of farm productivity and profitability.
The study, which looks at the Staphylococcus aureaus vaccine Startvac®, includes 8858 cows from 16 farms across three main dairy regions in New Zealand.
Bryan says European studies have shown that commercial vaccines have been successful in reducing the incidence, duration and severity of both subclinical and clinical mastitis.
"This has led to improved milk production, a lower culling rate, has increased the number of healthy cows within a herd, and reduced mastitis-related costs," he says.
"However, we need to assess how the vaccine performs under New Zealand conditions, particularly in reducing the number of clinical cases and Somatic Cell Count (SCC).
"The two key differences in the New Zealand system compared to the European are the seasonality of our industry and its pastorality. Most cows are grazed outside for the majority of the year, on pasture or other crops. However, with changes in intensification, New Zealand's dairy industry is becoming more similar to the European industry every season."
Bryan says that initial analyses indicate a possible difference in the proportion of cows with mastitis between treated and untreated cows (11.5% vs. 13.3% respectively). However, more data and further analysis are needed to judge the vaccine's effectiveness in the New Zealand farming environment.
The study involves the longitudinal effect of the vaccine within herds, placebo effects of taking part in a mastitis trial within a herd, and regional variations between herds.
"We are also looking at farm-level changes in behaviour and the impact on milk quality. Our assumption is that when farmers are enrolled in a study, their behaviour may change," says Bryan.
The study began during the dry period in the 2014-2015 season and will finish later this year.
A brilliant result and great news for growers and regional economies. That's how horticulture sector leaders are describing the news that sector exports for the year ended June 30 will reach $8.4 billion - an increase of 19% on last year and is forecast to hit close to $10 billion in 2029.
Funding is proving crucial for predator control despite a broken model reliant on the goodwill of volunteers.
A major milestone on New Zealand's unique journey to eradicate Mycoplasma bovis could come before the end of this year.
We're working through it, and we'll get to it.
The debate around New Zealand's future in the Paris Agreement is heating up.
A technical lab manager for Apata, Phoebe Scherer, has won the Bay of Plenty 2025 Young Grower regional title.
OPINION: It's official, Fieldays 2025 clocked 110,000 visitors over the four days.
OPINION: The Federated Farmers rural advocacy hub at Fieldays has been touted as a great success.